» Articles » PMID: 17512459

Molecular Mechanism of Human Nrf2 Activation and Degradation: Role of Sequential Phosphorylation by Protein Kinase CK2

Overview
Date 2007 May 22
PMID 17512459
Citations 77
Authors
Affiliations
Soon will be listed here.
Abstract

Nrf2 is a key transcription factor in the cellular response to oxidative stress. In this study we identify two phosphorylated forms of endogenous human Nrf2 after chemically induced oxidative stress and provide evidence that protein kinase CK2-mediated sequential phosphorylation plays potential roles in Nrf2 activation and degradation. Human Nrf2 has a predicted molecular mass of 66 kDa. However, immunoblots showed that two bands at 98 and 118 kDa, which are identified as phosphorylated forms, are increased in response to Nrf2 inducers. In addition, human Nrf2 was found to be a substrate for CK2 which mediated two steps of phosphorylation, resulting in two forms of Nrf2 migrating with differing M(r) at 98 kDa (Nrf2-98) and 118 kDa (Nrf2-118). Our results support a role in which calmodulin binding regulates CK2 activity, in that cold (25 degrees C) Ca(2+)-free media (cold/Ca(2+)-free) decreased both cellular calcium levels and CK2-calmodulin binding and induced Nrf2-118 formation, the latter of which was prevented by CK2-specific inhibitors. Gel shift assays showed that the Nrf2-118 generated under cold/Ca(2+)-free conditions does not bind to the antioxidant response element, indicating that Nrf2-98 has transcriptional activity. In contrast, Nrf2-118 is more susceptible to degradation. These results provide evidence for phosphorylation by CK2 as a critical controlling factor in Nrf2-mediated cellular antioxidant response.

Citing Articles

How to deal with frenemy NRF2: Targeting NRF2 for chemoprevention and cancer therapy.

Tang Y, Chuang Y, Chang H, Juang S, Yen G, Chang J J Food Drug Anal. 2024; 31(3):387-407.

PMID: 39666284 PMC: 10629913. DOI: 10.38212/2224-6614.3463.


Isoliquiritigenin as a modulator of the Nrf2 signaling pathway: potential therapeutic implications.

Qiu M, Ma K, Zhang J, Zhao Z, Wang S, Wang Q Front Pharmacol. 2024; 15:1395735.

PMID: 39444605 PMC: 11496173. DOI: 10.3389/fphar.2024.1395735.


Role of Oxidative Stress and Inflammation in Doxorubicin-Induced Cardiotoxicity: A Brief Account.

Vitale R, Marzocco S, Popolo A Int J Mol Sci. 2024; 25(13).

PMID: 39000584 PMC: 11242665. DOI: 10.3390/ijms25137477.


Formulation and Investigation of CK2 Inhibitor-Loaded Alginate Microbeads with Different Excipients.

Papp B, Le Borgne M, Perret F, Marminon C, Jozsa L, Peto A Pharmaceutics. 2023; 15(12).

PMID: 38140042 PMC: 10748227. DOI: 10.3390/pharmaceutics15122701.


The master antioxidant defense is activated during EBV latent infection.

Wang L, Howell M, Hensley C, Ning K, Moorman J, Yao Z J Virol. 2023; 97(11):e0095323.

PMID: 37877721 PMC: 10688347. DOI: 10.1128/jvi.00953-23.


References
1.
Zien P, Bretner M, Zastapilo K, Szyszka R, Shugar D . Selectivity of 4,5,6,7-tetrabromobenzimidazole as an ATP-competitive potent inhibitor of protein kinase CK2 from various sources. Biochem Biophys Res Commun. 2003; 306(1):129-33. DOI: 10.1016/s0006-291x(03)00928-8. View

2.
Leroy D, Heriche J, Filhol O, Chambaz E, Cochet C . Binding of polyamines to an autonomous domain of the regulatory subunit of protein kinase CK2 induces a conformational change in the holoenzyme. A proposed role for the kinase stimulation. J Biol Chem. 1997; 272(33):20820-7. DOI: 10.1074/jbc.272.33.20820. View

3.
Cullinan S, Zhang D, Hannink M, Arvisais E, Kaufman R, Diehl J . Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol. 2003; 23(20):7198-209. PMC: 230321. DOI: 10.1128/MCB.23.20.7198-7209.2003. View

4.
Pi J, Qu W, Reece J, Kumagai Y, Waalkes M . Transcription factor Nrf2 activation by inorganic arsenic in cultured keratinocytes: involvement of hydrogen peroxide. Exp Cell Res. 2003; 290(2):234-45. DOI: 10.1016/s0014-4827(03)00341-0. View

5.
Bloom D, Jaiswal A . Phosphorylation of Nrf2 at Ser40 by protein kinase C in response to antioxidants leads to the release of Nrf2 from INrf2, but is not required for Nrf2 stabilization/accumulation in the nucleus and transcriptional activation of antioxidant response.... J Biol Chem. 2003; 278(45):44675-82. DOI: 10.1074/jbc.M307633200. View